By NewsDesk @bactiman63
The Norwegian Medicines Agency has received several adverse reaction reports about younger vaccinated people who have had skin hemorrhages (small-spotted skin hemorrhages and / or larger or smaller blue spots) after the AstraZeneca COVID-19 vaccination. This is serious and can be a sign of decreased platelet count.
Health officials were informed yesterday of a report from Tynset about an unexpected death as a result of a brain hemorrhage after vaccination with COVID-19 Vaccine AstraZeneca.
Today, March 13, we received three more reports of severe cases of blood clots or cerebral hemorrhages in younger people who have received the AstraZeneca vaccine. These are now receiving treatment in hospitals.
Common to these patients is that they have had a reduced number of platelets in the blood. Blood clots and subsequent cerebral hemorrhage are a rare condition.
The Norwegian Institute of Public Health, or Folkehelseinstituttet (FHI) has put the AstraZeneca vaccine on pause.
FHI and the Norwegian Medicines Agency have initiated studies to investigate the connection between the vaccine and various forms of blood clots, such as stroke and blood clots in the lungs. These analyzes will take time.
- Russian authority: H5N8 avian influenza mutating strain has fairly high degree of probability of human-to-human transmission forecasts
- South Dakota reports 1st UK Coronavirus Variant B.1.1.7 cases
- Bacteriophage therapy: NIH awards $2.5 million in grants to support research
- DRC Ebola outbreak: Total cases rise to 12, Ebola Treatment Center vandalized
- Philippines say no reason to stop rollout of AstraZeneca COVID-19 vaccine
- Saudi Arabia health officials report two additional MERS cases in Riyadh
- Vaccination program against tick-borne encephalitis extended in Finland, Increase reported in Kirkkonummi and Sipoo
- Norway salmonella outbreak strain detected in imported beef from Germany